title: Safety of growth hormone treatment in patients previously treated for cancer.
abstract: This review provides an overview of the safety of growth hormone replacement therapy in individuals previously treated for cancer. The review focuses on the risk of disease recurrence and second neoplasm occurrence with special attention to data on childhood cancer survivors.
authors.affiliation: Division of Endocrinology, Department of Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN 38105-3678, USA. wassim.chemaitilly@stjude.org
authors.forename: Wassim
authors.initials: W
authors.lastname: Chemaitilly
authors.forename: Leslie L
authors.initials: LL
authors.lastname: Robison
mesh_terms: D000328:Adult; D001932:Brain Neoplasms / Q000150:complications / Q000209:etiology; D002648:Child; D006130:Growth Disorders / Q000188:drug therapy / Q000209:etiology; D013006:Growth Hormone / Q000009:adverse effects*; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D008579:Meningioma / Q000209:etiology; D009364:Neoplasm Recurrence, Local / Q000209:etiology; D009369:Neoplasms / Q000628:therapy*; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D016609:Neoplasms, Second Primary / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects; D017741:Survivors
chemical_list: D013006:Growth Hormone